Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | -0.21% | 239.82 | 1.3% | $789.32m | |
| MRNA | Moderna, Inc. | 4.90% | 68.37 | 0.0% | $722.18m | |
| IMMU | Immunomedics, Inc. | -0.09% | 85.23 | 11.0% | $688.57m | |
| NVAX | Novavax, Inc. | 9.20% | 111.86 | 96.5% | $611.95m | |
| GILD | Gilead Sciences, Inc. | -0.52% | 61.93 | 1.0% | $572.01m | |
| ILMN | Illumina, Inc. | 4.86% | 300.22 | 3.5% | $527.35m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.99% | 563.00 | 2.7% | $429.30m | |
| BIIB | Biogen, Inc. | -0.11% | 269.75 | 1.6% | $332.79m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.04% | 263.02 | 1.9% | $328.11m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.26% | 113.43 | 2.0% | $281.73m | |
| SRNE | Sorrento Therapeutics, Inc. | 3.05% | 9.47 | 1.5% | $253.86m | |
| EXAS | EXACT Sciences Corp. | 4.26% | 98.33 | 20.7% | $241.94m | |
| VXRT | Vaxart, Inc. | 5.37% | 7.26 | 0.0% | $209.24m | |
| SGEN | Seattle Genetics, Inc. | 1.76% | 182.59 | 6.0% | $207.47m | |
| MNTA | Momenta Pharmaceuticals, Inc. | 0.06% | 52.42 | 3.0% | $197.96m |
Company Profile
Novavax, Inc. is operates as a clinical-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology. The firm's vaccine candidates include ResVax and NanoFlu. It also develops immune stimulating saponin-based adjuvants through its wholly owned Swedish subsidiary, Novavax AB. The company was founded in 1987 and is headquartered in Gaithersburg, MD.